Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes.
Codeine and morphine pharmacokinetics among different CYP2D6 genotypes was compared in this study. Polymerase chain reaction tests were used to determine CYP2D6 genotypes in leukocyte deoxyribonucleic acid in 32 unrelated volunteers. Based on the genotypes, subjects were categorized into three groups: homozygous C/C188 (n = 8), heterozygous C/T188 (n = 12), and homozygous T/T188 (n = 12). Each subject was given a single oral dose of 30 mg codeine phosphate tablet after overnight fasting. Plasma concentration of codeine and 24-hour urinary morphine recovery were measured with HPLC. All three genotypes of subjects showed almost identical time profiles of plasma codeine. Urinary morphine glucuronide was hydrolyzed with beta-glucuronidase. The total recovered amount of morphine and glucuronides was 4349 +/- 646, 2564 +/- 242, and 1127 +/- 164 nmol (mean +/- SEM), respectively, for C/C188, C/T188, and T/T188 subjects (p < 0.05). The significant lower amount of urinary morphine but identical codeine plasma concentration suggested a lower partial clearance of the formation of morphine from codeine in T/T188 subjects. The results suggest a future study to assess the analgesic effect of codeine in different genotypes of CYP2D6 extensive metabolizers.
Tseng
C Y
CY
Department of Clinical Pharmacy, National Cheng Kung University, Medical College, Tainan, Taiwan.
Wang
S L
SL
Lai
M D
MD
Lai
M L
ML
Huang
J D
JD
D000328:Adult; D000704:Analysis of Variance; D044466:Asian People / Q000235:genetics*; D002851:Chromatography, High Pressure Liquid; D003061:Codeine / Q000097:blood / Q000493:pharmacokinetics*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D005838:Genotype; D006801:Humans; D008297:Male; D009020:Morphine / Q000652:urine*; D016133:Polymerase Chain Reaction; D012016:Reference Values
D009020:Morphine; D019389:Cytochrome P-450 CYP2D6; D003061:Codeine